Koers BioCardia Inc Nasdaq
Aandelen
US09060U1016
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 700K 653K | Omzet 2025 * | 700K 653K | Marktkapitalisatie | 9,94 mln. 9,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -15 mln. -13,99 mln. | Nettowinst (verlies) 2025 * | -19 mln. -17,72 mln. | EV/omzet 2024 * | 14,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 14,2 x |
K/w-verhouding 2024 * |
-0,88
x | K/w-verhouding 2025 * |
-0,76
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 66,15% |
Recentste transcriptie over BioCardia Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01-01-02 |
David McClung
DFI | Director of Finance/CFO | 61 | 01-09-13 |
Chief Tech/Sci/R&D Officer | - | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01-01-02 |
Jay Moyes
BRD | Director/Board Member | 70 | 01-01-11 |
Richard Krasno
BRD | Director/Board Member | 82 | 24-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,63% | 102 mld. | |
+1,62% | 96,29 mld. | |
+2,36% | 22,18 mld. | |
-16,67% | 21,2 mld. | |
-9,16% | 18,31 mld. | |
-38,74% | 17,38 mld. | |
-13,21% | 16,36 mld. | |
+5,41% | 13,97 mld. | |
+33,57% | 12,17 mld. |
- Beurs
- Aandelen
- Koers BCDA
- Koers